Volume 17, Number 10—October 2011
Letter
Diagnosis of Rickettsioses from Eschar Swab Samples, Algeria
Table
Acceptability of swab or biopsy samples from tick-bite eschars, Oran Teaching Hospital, Oran, Algeria, July 2009–October 2010
| Question | Answer, no. (%)* |
|||
|---|---|---|---|---|
| Eschar swab sample | Skin biopsy sample | Both samples | Nothing | |
| For medical or biologist practitioners, n = 78 | ||||
| In the case that your patient has a “tache noire,” what would you do to confirm the diagnosis? | 46 (59) | 5 (6.4) | 22 (28) | 5 (6.4) |
| If you have a “tache noire,” what do you do to confirm the diagnosis? |
57 (73) |
2 (2.5) |
9 (11.5) |
9 (11.5) |
| For patients, n = 58 | ||||
| In the case of inoculation eschar, which kind of medical procedure would you prefer your medical doctor to conduct? | 43 (74) | 78 (12) | 5 (8.6) | 3 (5.2) |
*p = 0.0001 for eschar swab sample vs. skin biopsy sample; p value not available for other parameters.
1These authors contributed equally to this article.
Page created: September 12, 2018
Page updated: September 12, 2018
Page reviewed: September 12, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.